AVANOS MEDICAL, INC. (AVNS)
AVANOS MEDICAL, INC. (ticker AVNS) is a medical technology company that designs, manufactures, and distributes surgical, pain management, and digestive health products for healthcare providers globally.
What the company does
Avanos Medical operates in the medical device space, focusing on two primary business franchises: Pain Management and Chronic Care. The company develops and sells specialized medical devices to hospitals, healthcare systems, outpatient surgical centers, and other healthcare facilities across more than 90 countries. Its product portfolio spans three main categories.
Digestive health solutions include enteral feeding systems and neonatal care products designed for patients requiring nutritional support, including the MIC-KEY brand line and Corpak feeding solutions. Acute pain management products provide non-opioid alternatives for pain control in the surgical and immediate post-operative settings, including the ON-Q surgical pain pump and Game Ready cold therapy systems. Interventional pain solutions address chronic pain through minimally invasive therapies, including radiofrequency ablation products for long-term pain management.
How it makes money
The company generates revenue primarily through the direct sale of medical devices to healthcare institutions and through wholesale distribution channels. Hospitals and healthcare facilities purchase its products for in-patient care, surgical procedures, and pain management protocols. Revenue streams come from both initial device sales and consumable supplies that customers replenish over time, creating recurring revenue bases across its installed device platforms.
Where it sits in its industry
Avanos operates in the medical device sector alongside larger diversified medical technology companies and specialized device manufacturers. The company competes in distinct segments—surgical pain management and enteral feeding—where it holds established market positions built on clinical evidence and healthcare provider relationships. Its focus on pain management devices aligns with the healthcare industry’s broader shift toward opioid-reduction strategies and alternatives, positioning it within an evolving clinical landscape.
How to research it
Investors can review Avanos’s regulatory filings through the SEC’s EDGAR database, including 10-K annual reports and 10-Q quarterly reports, which contain detailed financial statements, business segment performance, competitive positioning, and risk disclosures. The company publishes investor relations materials including earnings call transcripts and presentations on its investor relations website. Medical literature and clinical outcome studies support the clinical efficacy claims underlying its product lines.